Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mi-Ran Yun

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancerKyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung CancerJiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Nature Biomedical Engineering|April 3, 2019
Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptorsHong-Won Lee, Byoungsan Choi, Han Na Kang, et al.
Therapeutic Advances in Medical Oncology|October 24, 2024
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancerSun Min Lim, Stefanie S Schalm, Eun Ji Lee, et al.
Yonsei Medical Journal|December 16, 2021
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin TumorChun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung CancerMi Ran Yun, Dong Hwi Kim, Seok-Young Kim, et al.
Cancer Discovery|May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLCJiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
Plos One|May 9, 2020
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirusJang-Hoon Choi, Hye-Min Woo, Tae-Young Lee, et al.
Emerging Infectious Diseases|December 23, 2015
Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015Dae-Won Kim, You-Jin Kim, Sung Han Park, et al.
BMC Cancer|April 16, 2020
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancerHan Na Kang, Jae-Hwan Kim, A-Young Park, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancerKyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung CancerJiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Nature Biomedical Engineering|April 3, 2019
Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptorsHong-Won Lee, Byoungsan Choi, Han Na Kang, et al.
Therapeutic Advances in Medical Oncology|October 24, 2024
BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancerSun Min Lim, Stefanie S Schalm, Eun Ji Lee, et al.
Yonsei Medical Journal|December 16, 2021
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin TumorChun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung CancerMi Ran Yun, Dong Hwi Kim, Seok-Young Kim, et al.
Cancer Discovery|May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLCJiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
Plos One|May 9, 2020
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirusJang-Hoon Choi, Hye-Min Woo, Tae-Young Lee, et al.
Emerging Infectious Diseases|December 23, 2015
Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015Dae-Won Kim, You-Jin Kim, Sung Han Park, et al.
BMC Cancer|April 16, 2020
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancerHan Na Kang, Jae-Hwan Kim, A-Young Park, et al.
Pageof 7